Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
Akshara Richhariya1, Yi Qian2, Yufan Zhao2, Karen Chung11Amgen Inc, Global Health Economics, Thousand Oaks, CA, USA; 2Amgen Inc, Global Biostatistical Sciences, Thousand Oaks, CA, USAPurpose: Intravenous (IV) zoledronic acid (ZA) is commonly used to delay skeletal complications secondary to bone met...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-02-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/time-associated-with-intravenous-zoledronic-acid-administration-in-pat-a9322 |